Considering the striking therapeutic value of targeting NRPs for both models of cancers, we first analyzed the relative expression of NRPs and their ligands VEGFA and VEGFC on a panel of cell lines available in the TCGA data base. The gene discussed is VEGFA; the disease is cancer.